AKT1 and cancer: COMP also promotes cancer cell stemness by increasing the interaction between Notch3 and its ligand Jagged1, resulting in increased activation of Jagged1-Notch3 signaling and cross-reactivity with other important cancer-related pathways, such as AKT and β-catenin [10].